180 Collagen (NZ) Limited
↗Te Awamutu, New Zealand
180 Collagen is a New Zealand-based biotechnology company that specializes in the development, manufacture, and supply of medical-grade bovine collagen. The company operates a unique, vertically integrated model where collagen is harvested from their own prime beef cattle on a 300-hectare farm, processed in an on-site, purpose-built facility, and refined into high-purity collagen products.
Their products are utilized in research, medical devices, and regenerative medicine applications, including wound care dressings, skin replacements, mesh implants, dental membranes, and bone scaffolds. The company emphasizes traceability, GMP compliance, and adherence to international standards such as ISO 13485:2016.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Biomaterials / Medical Devices
SIZE & FINANCIALS
Employees:1-50
Founded:2019
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Biomaterials
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Mohamed Bashir - Global Head of Business Development
LINKS
Website:180collagen.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of 180 Collagen (NZ) Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with 180 Collagen (NZ) Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.